These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
535 related items for PubMed ID: 26173861
1. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study. Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT. Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861 [Abstract] [Full Text] [Related]
2. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease. Filippi M, Canu E, Donzuso G, Stojkovic T, Basaia S, Stankovic I, Tomic A, Markovic V, Petrovic I, Stefanova E, Kostic VS, Agosta F. Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420 [Abstract] [Full Text] [Related]
3. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition. Foo H, Mak E, Yong TT, Wen MC, Chander RJ, Au WL, Sitoh YY, Tan LC, Kandiah N. Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468 [Abstract] [Full Text] [Related]
4. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally. Hanganu A, Bedetti C, Degroot C, Mejia-Constain B, Lafontaine AL, Soland V, Chouinard S, Bruneau MA, Mellah S, Belleville S, Monchi O. Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932 [Abstract] [Full Text] [Related]
5. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? Duncan GW, Firbank MJ, Yarnall AJ, Khoo TK, Brooks DJ, Barker RA, Burn DJ, O'Brien JT. Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802 [Abstract] [Full Text] [Related]
6. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease. Ong M, Foo H, Chander RJ, Wen MC, Au WL, Sitoh YY, Tan L, Kandiah N. J Neurol Sci; 2017 Jun 15; 377():122-126. PubMed ID: 28477681 [Abstract] [Full Text] [Related]
7. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease. Foo H, Mak E, Yong TT, Wen MC, Chander RJ, Au WL, Tan L, Kandiah N. Parkinsonism Relat Disord; 2016 Oct 15; 31():34-40. PubMed ID: 27397577 [Abstract] [Full Text] [Related]
8. Cortical thinning associated with mild cognitive impairment in Parkinson's disease. Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Garcia-Diaz AI, Vendrell P, Bargallo N, Tolosa E, Junque C. Mov Disord; 2014 Oct 15; 29(12):1495-503. PubMed ID: 25100674 [Abstract] [Full Text] [Related]
9. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition. Kunst J, Marecek R, Klobusiakova P, Balazova Z, Anderkova L, Nemcova-Elfmarkova N, Rektorova I. Brain Topogr; 2019 Jan 15; 32(1):142-160. PubMed ID: 30206799 [Abstract] [Full Text] [Related]
10. Cortical thinning across Parkinson's disease stages and clinical correlates. Wilson H, Niccolini F, Pellicano C, Politis M. J Neurol Sci; 2019 Mar 15; 398():31-38. PubMed ID: 30682518 [Abstract] [Full Text] [Related]
12. Grey matter atrophy in cognitively impaired Parkinson's disease. Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ. J Neurol Neurosurg Psychiatry; 2012 Feb 15; 83(2):188-94. PubMed ID: 21890574 [Abstract] [Full Text] [Related]
13. Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease. Chung SJ, Shin JH, Cho KH, Lee Y, Sohn YH, Seong JK, Lee PH. Mov Disord; 2017 Oct 15; 32(10):1447-1456. PubMed ID: 28737237 [Abstract] [Full Text] [Related]
14. Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease. Price CC, Tanner J, Nguyen PT, Schwab NA, Mitchell S, Slonena E, Brumback B, Okun MS, Mareci TH, Bowers D. PLoS One; 2016 Oct 15; 11(1):e0147332. PubMed ID: 26784744 [Abstract] [Full Text] [Related]
15. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology. Gao Y, Nie K, Huang B, Mei M, Guo M, Xie S, Huang Z, Wang L, Zhao J, Zhang Y, Wang L. Neurosci Lett; 2017 Sep 29; 658():121-132. PubMed ID: 28823894 [Abstract] [Full Text] [Related]
16. Initial cognitive decline is associated with cortical thinning in early Parkinson disease. Pereira JB, Svenningsson P, Weintraub D, Brønnick K, Lebedev A, Westman E, Aarsland D. Neurology; 2014 Jun 03; 82(22):2017-25. PubMed ID: 24808018 [Abstract] [Full Text] [Related]
17. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, Tolosa E, Martí MJ. J Neurol Neurosurg Psychiatry; 2013 Aug 03; 84(8):875-81. PubMed ID: 23463873 [Abstract] [Full Text] [Related]
18. Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis. Mak E, Bergsland N, Dwyer MG, Zivadinov R, Kandiah N. AJNR Am J Neuroradiol; 2014 Dec 03; 35(12):2257-64. PubMed ID: 25082821 [Abstract] [Full Text] [Related]
19. Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up. Uribe C, Segura B, Baggio HC, Abos A, Garcia-Diaz AI, Campabadal A, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C. Parkinsonism Relat Disord; 2019 Jul 03; 64():286-292. PubMed ID: 31103485 [Abstract] [Full Text] [Related]
20. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations. Goldman JG, Stebbins GT, Dinh V, Bernard B, Merkitch D, deToledo-Morrell L, Goetz CG. Brain; 2014 Mar 03; 137(Pt 3):849-59. PubMed ID: 24480486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]